SS-31 Peptide (Elamipretide) Dosage Guide, Benefits & Side Effects

Lyophilized (freeze-dried, unreconstituted) SS-31 is generally recommended to be stored frozen at approximately -20°C for long-term storage (commonly cited stability up to ~24 months), or refrigerated at 2-8°C for shorter-term storage (up to a few months). Once reconstituted with bacteriostatic or sterile water, the solution should be kept refrigerated at 2-8°C and is typically recommended for use within about 4 weeks; reconstituted solution should not be refrozen, as freeze-thaw cycles can degrade the peptide. These are general peptide-handling conventions reported by suppliers and community sources rather than official prescribing guidance, since SS-31 (as elamipretide) approved use follows its own clinical formulation and handling protocol.

Plasma half-life after subcutaneous administration is reported to be relatively short, on the order of about 2 hours, with peak plasma concentration (Cmax) reached roughly 1-2 hours after injection. However, because SS-31 binds with high affinity to cardiolipin in mitochondrial membranes, tissue retention in organs like the heart, kidney, and muscle is reported to be considerably longer than plasma levels would suggest. This is part of why most protocols, whether clinical or community-reported, use once-daily subcutaneous dosing rather than multiple daily doses.

There are no formal clinical studies evaluating SS-31 in combination with other peptides. Community and vendor discussions sometimes mention pairing it with peptides like Epithalon on the rationale that they act through different, potentially complementary mechanisms (mitochondrial/cardiolipin support versus other cellular pathways), but this is speculative and based on anecdotal reports rather than controlled research. Anyone considering combining research compounds should recognize that interaction effects and safety are largely unstudied.

As the approved drug elamipretide, SS-31 is available by prescription for its FDA-approved indication (Barth syndrome). Separately, unapproved SS-31 peptide is sold by research-chemical suppliers labeled strictly for laboratory/research use, not for human consumption. Regulations on purchasing and possessing research peptides vary by country and region, and quality/purity can vary significantly between suppliers, a recurring complaint in online peptide communities. Buyers should be aware that product sold this way is not regulated, tested, or approved for human use in the way the prescription product is.